Previous 10 | Next 10 |
2023-11-09 19:45:14 ET Image source: The Motley Fool. Organogenesis (NASDAQ: ORGO) Q3 2023 Earnings Call Nov 09, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis (ORGO) Q3 2023 Earnings Call Transcript
2023-11-09 16:27:34 ET Organogenesis Holdings press release ( NASDAQ: ORGO ): Q3 GAAP EPS of $0.02. Revenue of $108.5M (-7.2% Y/Y). Sees 2023 Net revenue between $433 million and $446 million. Sees 2023 Net income between $4 million and $9 million and adjusted net ...
CANTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today re...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Organogenesis Holdings Inc. (ORGO) is expected to report $0.01 for Q3 2023
CANTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...
2023-09-28 12:59:55 ET Gainers: Baudax Bio ( BXRX ) +75% . Chico's Fas ( CHS ) +63% . Aytu BioPharma ( AYTU ) +35% . Axcella Health ( AXLA ) +35% . Vaccinex ( VCNX ) +33% . Organogenesis Holdings ( ORGO ) +27% . F...
2023-09-28 12:57:33 ET More on Organogenesis Organogenesis Holdings, Inc. (ORGO) Q2 2023 Earnings Call Transcript Organogenesis: Solid Revenue Generation From A Hyper-Trading Wound Care Company Organogenesis tumbles after pulling 2023 guidance Seeking Alpha...
2023-09-28 11:44:05 ET Shares of Organogenesis Holdings (NASDAQ: ORGO) were up more than 22% as of 11:15 a.m. on Thursday. The healthcare company's stock is up more than 19% this year. Organogenesis focuses on solutions for the advanced wound care and surgical and sports med...
2023-09-28 10:00:05 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...